Nu Skin Enterprises, Inc.
NUS
$10.27
$0.020.20%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.56B | 1.63B | 1.68B | 1.73B | 1.78B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.56B | 1.63B | 1.68B | 1.73B | 1.78B |
| Cost of Revenue | 473.03M | 494.22M | 505.72M | 511.43M | 454.34M |
| Gross Profit | 1.09B | 1.13B | 1.17B | 1.22B | 1.32B |
| SG&A Expenses | 988.14M | 1.04B | 1.08B | 1.13B | 1.17B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.46B | 1.53B | 1.59B | 1.64B | 1.63B |
| Operating Income | 99.23M | 95.82M | 88.83M | 89.58M | 149.75M |
| Income Before Tax | 120.20M | 117.51M | -41.55M | -175.05M | -107.92M |
| Income Tax Expenses | 10.60M | 16.68M | -3.01M | -28.46M | -4.71M |
| Earnings from Continuing Operations | 109.61 | 100.83 | -38.55 | -146.59 | -103.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 109.61M | 100.83M | -38.55M | -146.59M | -103.21M |
| EBIT | 99.23M | 95.82M | 88.83M | 89.58M | 149.75M |
| EBITDA | 155.03M | 156.85M | 154.41M | 159.39M | 221.69M |
| EPS Basic | 2.21 | 2.03 | -0.78 | -2.95 | -2.08 |
| Normalized Basic EPS | 1.74 | 1.35 | 0.87 | 0.83 | 1.57 |
| EPS Diluted | 2.18 | 2.01 | -0.80 | -2.95 | -2.08 |
| Normalized Diluted EPS | 1.73 | 1.35 | 0.87 | 0.83 | 1.57 |
| Average Basic Shares Outstanding | 198.32M | 198.62M | 198.87M | 198.65M | 198.34M |
| Average Diluted Shares Outstanding | 199.85M | 199.27M | 199.46M | 198.67M | 198.44M |
| Dividend Per Share | 0.24 | 0.24 | 0.24 | 0.24 | 0.57 |
| Payout Ratio | 10.87% | 11.83% | -31.00% | -8.14% | -27.34% |